USPTO 2015–2025 USPTO PatentsView US Corporation

Tula Health Inc

USPTO PatentsView assignee record - 20 granted patents across 18 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

The verdict

According to USPTO PatentsView, Tula ranks #15,018 of 50,000 tracked US assignees by granted-patent volume, with 20 patents across 18 technology areas.

#15,018
of 50,000 US assignees by volume
Top 6%
by Innovation Score (57.0/100)
19.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15018 · US Corporation #15,018 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 20 grants
  • MID-PACK #15,018/50,000
  • PHOTO-FINISH Toly Management
  • CPC-FOCUS A61B · 18 areas
  • INNOV-PAR 57.0/100
  • CLAIMS-RICH 19.1 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2024 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Toly Management Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Tula

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tula Health Inc stamps GRANTS-SMALL, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-USCORP, SPAN-YRS, BOOK-RICH. Volume places it #15,018 of 50,000; Innovation Score 57.0/100 sits in the top 6% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Toly Management Ltd. (±0 grants).

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Portfolio overview

Tula Health Inc has been granted 20 US utility patents between 2020 and 2024, placing Tula Health Inc at #15,018 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Tula Health Inc is one of the more focused assignees in the PatentsView dataset. By volume, Tula sits between Toly Management Ltd. (20 patents, rank #15,008) and Unifor S.p.a. (20 patents, rank #15,016) - the closest US assignees by grant volume. The composite Innovation Score of 57.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2024, with 20 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Tula Health Inc's 19.1 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 18 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Tula's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Tula holds 20 patents at rank #15,012, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Tula

By rank, the assignees closest to #15,012 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Tula's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Tula, neither rank-band nor same-CPC leaders (those blocks stay above).

Tula's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2020202120232024 7
USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Tula Health Inc patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 5.0%
2021 3 15.0%
2023 9 45.0%
2024 7 35.0%

Where it ranks

Overall rank by patents

#15,018

of 50,000 tracked assignees

Innovation Score

57.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.